clinical trials

New Delhi/Bhubaneswar: As the global community is in the thick of developing a cure for COVID-19, an Ayurvedic clinical trial has shown promising results. The interim report on a trial…

New Delhi: The Drugs Controller General of India (DCGI) has given permission to Serum Institute of India, a Pune-based vaccine maker, to resume the Phase 2 and Phase 3 clinical trials of the…

The clinical trials of the COVID-19 vaccine candidate being developed by Oxford University and AstraZeneca may have been put on pause following an adverse reaction observed in one of the…

Moscow: If reports in Russian media are to be believed, a potential vaccine for novel coronavirus being developed by Gamaleya Institute in Moscow has completed clinical trials, and the…

Moscow: Even as Oxford University’s vaccine was being considered to be the frontrunner in the race against COVID-19, Sechenov First Moscow State Medical University in Russia has completed…

New Delhi: The most worrisome feature of novel coronavirus is that a patient without any symptom can be the 'silent spreader'. There are a wide range of symptoms of the deadly virus, many of…

The World Health Organisation (WHO) has identified the vaccine developed by Oxford University-AstraZeneca and Moderna Inc as frontrunners in the race against the coronavirus pandemic.…

New Delhi: The Drug Controller General of India (DCGI) has approved the use of oral antiviral drug Favipiravir for clinical trials in the treatment of mild to moderate cases of COVID-19.…